Nebivolol is devoid of intrinsic sympathomimetic activity.
暂无分享,去创建一个
R. Reneman | P. Janssen | A. Van de Water | W. Janssens | R. Xhonneux | J. M. Nueten | J. van Nueten | A. Water
[1] R. Reneman,et al. Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist. , 1988, Journal of cardiovascular pharmacology.
[2] U. Borchard,et al. In vitro studies on the pharmacological properties of diacetolol, the major metabolite of acebutolol in man. , 1985, Archives internationales de pharmacodynamie et de therapie.
[3] P. Vanhoutte,et al. Pharmacology of bucindolol in isolated canine vascular smooth muscle. , 1984, The Journal of pharmacology and experimental therapeutics.
[4] B. J. Clark,et al. Pindolol--the pharmacology of a partial agonist. , 1982, British journal of clinical pharmacology.
[5] R. Snyder,et al. β-adrenoceptor and cardiovascular effects of MJ 13105 (Bucindolol) in anesthetized dogs and rats , 1980 .
[6] R. Reneman,et al. On-line computation of cardiac output with the thermodilution method, using a digital minicomputer. , 1976, Cardiovascular research.
[7] J. Bollman. A cage which limits the activity of rats. , 1948, The Journal of laboratory and clinical medicine.